###begin article-title 0
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brain
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Microarray analysis of gene expression in the cerebral cortex and hippocampus of mice deficient in cyclooxygenase-1 or cyclooxygenase-2 reveals that the two enzymes differentially modulate brain gene expression.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 252 254 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 650 653 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 670 673 666 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
Cyclooxygenase (COX)-1 and COX-2 produce prostanoids from arachidonic acid and are thought to have important yet distinct roles in normal brain function. Deletion of COX-1 or COX-2 results in profound differences both in brain levels of prostaglandin E2 and in activation of the transcription factor nuclear factor-kappaB, suggesting that COX-1 and COX-2 play distinct roles in brain arachidonic acid metabolism and regulation of gene expression. To further elucidate the role of COX isoforms in the regulation of the brain transcriptome, microarray analysis of gene expression in the cerebral cortex and hippocampus of mice deficient in COX-1 (COX-1-/-) or COX-2 (COX-2-/-) was performed.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 317 321 317 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
A majority (>93%) of the differentially expressed genes in both the cortex and hippocampus were altered in one COX isoform knockout mouse but not the other. The major gene function affected in all genotype comparisons was 'transcriptional regulation'. Distinct biologic and metabolic pathways that were altered in COX-/- mice included beta oxidation, methionine metabolism, janus kinase signaling, and GABAergic neurotransmission.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
Our findings suggest that COX-1 and COX-2 differentially modulate brain gene expression. Because certain anti-inflammatory and analgesic treatments are based on inhibition of COX activity, the specific alterations observed in this study further our understanding of the relationship of COX-1 and COX-2 with signaling pathways in brain and of the therapeutic and toxicologic consequences of COX inhibition.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 535 536 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 576 579 576 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 596 599 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 539 543 <span type="species:ncbi:10090">Mice</span>
Prostaglandin H synthase, otherwise known as cyclooxygenase (COX), catalyzes the first metabolic step in the transformation of arachidonic acid (AA) to the bioactive products prostaglandins and thromboxanes [1]. The existence of two isoforms of prostaglandin H synthase, namely COX-1 and COX-2, has been confirmed in multiple organs, including brain [2,3]. Not only are these enzymes physiologically important in their role in AA metabolism but they are also important pharmacologic targets of analgesics and anti-inflammatory agents [3]. Mice deficient in either COX-1 (COX-1-/-) or COX-2 (COX-2-/-) are available and have been used to advance our understanding of the physiologic and pathologic roles of the individual COX isoforms [4].
###end p 10
###begin p 11
###xml 322 326 322 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 335 339 335 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 364 368 364 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 506 508 506 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 513 514 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 545 547 545 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 610 614 610 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 662 664 662 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 693 695 693 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 780 781 780 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 866 870 866 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 897 901 897 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 953 957 953 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 966 970 966 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1081 1082 1073 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1083 1084 1075 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
Although it is known that in brain both COX-1 and COX-2 are expressed constitutively and that COX-2 can be induced upon the presence of an insult, complete understanding of the role of each individual isoform is lacking. Our laboratory has attempted to elucidate the role of each isoform on brain physiology by using COX-1-/- and COX-2-/- mice. We found that COX-2-/- mice have altered expression and activity of enzymes in the AA metabolism cascade, including increases in COX-1, cytosolic phospholipase A2 (cPLA2) and secretory phospholipase A2 expression [5]. Similar alterations have been observed in COX-1-/- mice, in which COX-2 protein expression and cPLA2 and secretory phospholipase A2 gene and protein expression are increased [6]. However, the levels of prostaglandin E2, which is one of the major end products of the COX reaction, were increased in COX-1-/- mice but decreased in COX-2-/- mice. In addition, it has also been shown that COX-1-/- and COX-2-/- mice exhibit profound differences in activation of the transcription factor nuclear factor-kappaB (NF-kappaB) [6,7]. Overall, these previous studies suggest that each isoform and their end products, which function through specific prostaglandin receptors, play a unique role in the regulation of gene expression in the brain.
###end p 11
###begin p 12
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 546 550 546 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 559 563 559 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
It has also been shown that mice with genetic deletion of an individual COX isoform have altered responses to pathologic insults. For instance, COX-2-/- mice are known to be more resistant to direct cortical injections of N-methyl-D-aspartate, middle cerebral artery occlusion (MCAO), and systemic injections of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [8,9]. However, the precise downstream molecular mechanisms involved in these processes are not clearly characterized. Therefore, it is quite clear that an understanding of the COX-1-/- and COX-2-/- mouse brain transcriptome is necessary to elucidate further the individual roles of COX-1 and COX-2 in both normal brain function and response to injury.
###end p 12
###begin p 13
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1738 1742 1731 1735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1754 1758 1747 1751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 750 755 <span type="species:ncbi:10090">mouse</span>
###xml 904 911 <span type="species:ncbi:28980">Redwood</span>
###xml 1758 1762 <span type="species:ncbi:10090">mice</span>
Although previously characterized alterations in gene and protein expression in COX-deficient mice have been examined, they were discovered in a 'one protein and one gene at a time fashion' using Western blotting and real-time polymerase chain reaction (PCR) [5-7]. The usage of high-throughput technology such as microarray analysis can enhance our ability to characterize the effect of deleting the expression of either COX-1 or COX-2 on the expression of networks of genes normally controlled by the end products of these individual COX isoforms. Therefore, we used microarray analysis with quantitative, real-time PCR (Q-PCR) validation to determine the effect of deletion of either COX-1 or COX-2 on the transcriptome of two separate regions of mouse brain, namely hippocampus and cerebral cortex. Further analysis of the entire dataset with Ingenuity Pathways analysis software (Ingenuity Systems, Redwood City, CA, USA), a web-based software application that assists in the analysis and elucidation of complex biologic systems, revealed specific networks of genes that were differentially regulated. We decided to focus on gene expression changes that comprised specific biologic functions, and not just individual genes that are affected by genetic deletion of individual COX isoforms. Our findings suggest that genetic ablation of COX activity alters the transcription of a multitude of genes. Furthermore, we demonstrate that genetic deletion of COX isoforms alters the expression of tandem genes that are involved in metabolic and signaling pathways such as beta oxidation, methionine metabolism, gamma-aminobutyric acid (GABA) neurotransmission, and cytokine signaling. We also describe genes differentially expressed in COX-1-/- versus COX-2-/- mice, suggesting a unique role for COX-1 or COX-2 in modulating gene expression.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 37 41 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Differential gene expression in COX-1-/- and COX-2-/- mice
###end title 15
###begin p 16
###xml 71 75 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 96 100 96 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 239 243 239 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
In the cerebral cortex, 94 genes were differentially expressed in COX-1-/- mice and 157 in COX-2-/- mice compared with respective wild-type mice. In the hippocampus, 182 genes were differentially expressed in COX-1-/- mice and 168 in COX-2-/- mice compared with wild-type mice. These genes represent the entire set of differentially expressed genes, including expressed sequence tags, and RIKEN and chromosomal segment sequences. Further description of this dataset includes only the subset of genes that were annotated with an ascribed function or gene name. A complete list of the annotated, differentially expressed genes for both brain regions and all genotype comparisons can be found in the Additional data files, and the entire raw dataset can be found in the Gene Expression Omnibus (GEO: GSE5342).
###end p 16
###begin p 17
###xml 197 201 197 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 210 214 210 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 411 415 411 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 430 434 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 458 462 458 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 477 481 477 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 494 498 494 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 670 674 670 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 903 907 903 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 923 927 923 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 927 931 <span type="species:ncbi:10090">mice</span>
Using DRAGON (Database Referencing of Array Genes Online), SwissProt function labels were ascribed to each gene and genes were parsed into categories according to the function labels. In both COX-1-/- and COX-2-/- mice, the greatest number of genes whose expression was significantly changed in both brain regions belonged to the SwissProt function category of transcriptional regulation (cerebral cortex: COX-1-/- = 12% and COX-2-/- = 7%; hippocampus: COX-1-/- = 11% and COX-2-/- = 12%). COX-2-/- mice exhibited significant changes in expression of genes belonging to the transmembrane (6%) and mitochondrion (5%) functional categories in cerebral cortex, whereas COX-1-/- mice exhibited significant alteration in expression of genes classified as nuclear proteins (9%). In contrast, expression of genes belonging to the kinases (7%) functional group was selectively changed in the hippocampus of COX-1-/- but not of COX-2-/- mice.
###end p 17
###begin p 18
###xml 115 119 115 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 127 131 127 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 252 256 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 265 269 265 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 348 352 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 361 365 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 503 507 503 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 516 520 516 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 814 818 810 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 842 846 838 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1051 1055 1047 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1064 1068 1060 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1173 1174 1169 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
###xml 1068 1072 <span type="species:ncbi:10090">mice</span>
###xml 1161 1165 <span type="species:ncbi:10090">mice</span>
Although a majority of the genes (>93%) shown to be differentially expressed in the separate brain regions of COX-1-/- or COX-2-/- mice only occurred in mice null for one isoform and not the other, the expression of some genes was changed in both COX-1-/- and COX-2-/- mice. Table 1 lists all of the genes whose expression was changed in both COX-1-/- and COX-2-/- mice, either in the same or in the opposite direction. In the cerebral cortex, there were four genes with altered expression in both COX-1-/- and COX-2-/- mice. Of these four, Rho-GDP dissociation inhibitor alpha exhibited increased expression in both genotypes. The expression of the other three genes (mitochondrial inner membrane protein, GABA transporter [GAT]3, and ring finger protein 24) changed in opposite directions (downregulated in COX-1-/- and upregulated in COX-2-/- mice), suggesting an isoform-specific effect on expression of these genes. Such an isoform-specific effect was not observed in the hippocampus, where all 12 genes whose expression was altered in both COX-1-/- and COX-2-/- mice exhibited changes in a similar direction in both genotypes when compared with wild-type mice (Table 1), suggesting that this cohort of genes is responsive to a general alteration in AA metabolism that is not specific to COX-1 or COX-2.
###end p 18
###begin p 19
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 216 218 216 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 233 235 233 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 249 251 249 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 299 301 299 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 317 319 317 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 333 335 333 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 425 427 425 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 499 501 499 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 435 440 <span type="species:ncbi:10090">mouse</span>
###xml 509 512 <span type="species:ncbi:10116">rat</span>
Upregulation of gene expression of cPLA2, which releases AA from phospholipids, as previously described by Q-PCR in whole brain of COX-1-/- and COX-2-/- mice [5,6], was not detected in cortex (COX-1: z ratio = 0.72, P = 0.03; COX-2: z ratio = 0.04, P = 0.9) and hippocampus (COX-1: z ratio = -0.89, P = 0.002; COX-2: z ratio = 0.60, P = 0.13) by microarray analysis. Although a thorough study regarding the expression of cPLA2 mRNA in mouse brain has not been undertaken, expression patterns of cPLA2 mRNA in rat brain suggest elevated expression in the midbrain, thalamus, hypothalamus, pons, and pineal gland compared with cerebral cortex and hippocampus [10]. Therefore, this heterogeneous expression of cPLA may account for the detection of differential regulation in whole brain but not in distinct regions, such as hippocampus and cortex.
###end p 19
###begin p 20
###xml 243 244 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 277 278 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 325 326 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 403 404 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
Using Ingenuity Pathways analysis software, we identified specific networks of genes that were differentially regulated. These networks of genes constituted specific metabolic and signaling pathways, including beta oxidation of lipids (Figure 1), methionine metabolism (Figure 2), GABAergic neurotransmitter signaling (Table 2), and a COX isoform specific effect on Janus kinase (JAK) expression (Table 2).
###end p 20
###begin title 21
###xml 80 84 80 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Expression of genes involved in beta oxidation is upregulated in cortex of COX-2-/- mice
###end title 21
###begin p 22
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 320 321 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 425 429 422 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 441 443 438 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 537 541 532 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 585 587 578 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 606 608 599 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 680 684 673 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 690 692 683 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 768 772 759 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 816 818 805 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 837 839 826 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 943 947 932 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 953 955 942 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 1040 1044 1027 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1088 1090 1073 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 1109 1111 1094 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1233 1237 1218 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1278 1282 1261 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1326 1328 1307 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 1346 1348 1327 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
###xml 1237 1241 <span type="species:ncbi:10090">mice</span>
###xml 1282 1286 <span type="species:ncbi:10090">mice</span>
###xml 1320 1324 <span type="species:ncbi:10090">mice</span>
In cerebral cortex of COX-2-/- mice, we identified increased expression of three genes that work in tandem in the final steps of short chain lipid metabolism by beta oxidation, namely hydroxyacyl-coenzyme A dehydrogenase type II (HADH2), acetyl-coenzyme A acetyltransferase 1 (ACAT1) and ATP citrate lyase (ACLY; Figure 1). Expression of HADH2 was determined to be increased in microarray analysis of cerebral cortex of COX-2-/- mice with a z ratio of +1.60. Q-PCR also demonstrated an increase in HADH2 expression (143% +/- 24% in COX-2-/- mice versus 100% +/- 20% in wild-type mice; t statistic = -3.26, P = 0.01). ACAT1 expression was also increased in cerebral cortex of COX-2-/- mice (z ratio = +1.83), which was validated by Q-PCR analysis (158% +/- 19% in COX-2-/- mice versus 100% +/- 10% in wild-type mice; t statistic = -6.13, P = 0.0003). Finally, ACLY expression was increased in microarray analysis of the cerebral cortex of COX-2-/- mice (z ratio = +1.65), and the increase was also validated with Q-PCR (188% +/- 33% in COX-2-/- mice versus 100% +/- 49% in wild-type mice; t statistic = -3.41, P = 0.008). Gene expression of ACAT 1, but not that of HADH2 and ACLY, was found to be decreased in the hippocampus of COX-1-/- mice (z ratio= -3.00; 72% +/- 6% in COX-1-/- mice versus 100% +/- 21% in wild-type mice; t statistic = 2.99, P = 0.03).
###end p 22
###begin title 23
###xml 87 91 87 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Expression of genes involved in methionine metabolism is upregulated in cortex of COX-2-/- mice
###end title 23
###begin p 24
###xml 212 216 212 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 300 302 300 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 361 365 359 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 409 411 405 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 430 432 426 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 505 507 501 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 566 570 560 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 614 616 606 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 635 637 627 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 706 710 698 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 723 725 715 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 760 764 750 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 808 810 796 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 828 830 816 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
Expression of methionine adenosyltransferase II (MAT2B) and adenosylhomocysteine hydrolase (AHCY), two genes that work in tandem to metabolize methionine to homocysteine, was increased in cerebral cortex of COX-2-/- mice (Figure 2). MAT2B expression was found to be increased in microarray analysis (z ratio = +2.79) and by Q-PCR analysis (138% +/- 12% in COX-2-/- mice versus 100% +/- 25% in wild-type mice; t statistic = -3.14, P = 0.013). Increased AHCY expression, as detected by microarray analysis (z ratio= +1.66), was validated by Q-PCR (123% +/- 5% in COX-2-/- mice versus 100% +/- 14% in wild-type mice; t statistic = -3.76, P = 0.01). Expression of MAT2B, but not of AHCY, was decreased in COX-1-/- hippocampus (z ratio = -3.07; 78% +/- 13% in COX-1-/- mice versus 100% +/- 18% in wild-type mice; t statistic = 2.39, P = 0.04).
###end p 24
###begin title 25
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
GABA transporter and receptor expression is altered in COX-/- mice
###end title 25
###begin p 26
###xml 190 192 187 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 228 232 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 266 268 263 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 309 310 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 424 428 421 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 454 458 449 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 502 504 495 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 522 524 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 586 590 579 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 680 684 671 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 728 730 717 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 748 750 737 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
Expressions of two genes that are involved in GABA neurotransmission were altered in cerebral cortex and hippocampus of COX knockout mice. Microarray analysis of GABA-A receptor subunit beta1 (GABRB1) in the hippocampus of COX-2-/- mice demonstrated downregulation (z ratio = -2.32) of gene expression (Table 2). Validation with Q-PCR demonstrated that the expression of GABRB1 was not only decreased in hippocampus of COX-2-/- mice (54% +/- 18% in COX-2-/- mice versus 100% +/- 19% in wild-type mice; t statistic = 4.08, P = 0.003) but it was also decreased in cerebral cortex of COX-2-/- mice, a change that was not initially detected by microarray analysis (72% +/- 8% in COX-2-/- mice versus 100% +/- 17% in wild-type mice; t statistic = 3.67, P = 0.008).
###end p 26
###begin p 27
###xml 60 64 60 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 122 126 122 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 209 213 209 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 248 250 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 340 344 340 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 370 374 368 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 418 420 414 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 438 440 434 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 458 462 454 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 489 493 483 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 537 539 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 558 560 550 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
GABA transporter (GAT)3 expression in cerebral cortex of COX-/- mice exhibited a genotype-specific effect (Table 2). COX-1-/- mice demonstrated downregulation of gene expression (z ratio = -1.86) whereas COX-2-/- showed upregulation of mRNA level (z ratio = +1.68). Validation with Q-PCR demonstrated the same pattern of expression in COX-1-/- mice (58% +/- 12% in COX-1-/- mice versus 100% +/- 22% in wild-type mice; t statistic = 3.70, P = 0.006) and COX-2-/- mice (166% +/- 37% in COX-2-/- mice versus 100% +/- 13% in wild-type mice; t statistic = -3.82, P = 0.01). No significant difference in the expression of GAT3 was detected by microarray or Q-PCR in the hippocampus of any mice examined in the present study (data not shown).
###end p 27
###begin title 28
Janus kinase expression is altered in a genotype-dependent manner in hippocampus
###end title 28
###begin p 29
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 125 129 125 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 168 170 168 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 274 278 274 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 305 309 303 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 353 355 349 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 374 376 370 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 443 447 439 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 463 467 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 473 475 469 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 568 572 562 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 616 618 608 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 636 638 628 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
Janus kinase (JAK) isoforms 1 and 2 were found to be expressed in a genotype-dependent manner in hippocampus (Table 2). COX-1-/- mice had increased expression of JAK1 (z ratio = +1.56) but not of JAK2. Q-PCR validation also demonstrated increased expression of JAK1 in COX-1-/- mice (196% +/- 79% in COX-1-/- mice versus 100% +/- 40% in wild-type mice; t statistic = -2.45, P = 0.04). On the other hand, JAK-2 expression was decreased in COX-2-/- but not in COX-1-/- mice (z ratio = -2.09). Validation with Q-PCR confirmed this selective decrease (82% +/- 12% in COX-2-/- mice versus 100% +/- 10% in wild-type mice; t statistic = 2.54, P = 0.03). No significant differences in expression of JAK-1 or JAK-2 were observed in cerebral cortex (data not shown).
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 40 44 40 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 52 56 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
In this study, we demonstrate that COX-1-/- or COX-2-/- mice exhibit significant changes in the hippocampus and cerebral cortex transcriptome. Some differentially expressed genes occur in both genotypes but most changes observed (>93%) are unique to one isoform deletion and not the other. This observation implies that despite the functional similarities of the two COX isoforms in the metabolism of AA to eicosanoids, they impact the basal physiology of the brain in different ways. Because the end products of COX-mediated AA metabolism, through the subsequent action of thromboxane and prostaglandin synthases, are the bioactive mediators of COX activity, this study suggests that COX-1 or COX-2 specific end products differentially affect the mouse brain transcriptome.
###end p 31
###begin title 32
Altered expression of mitochondrial function and beta oxidation genes
###end title 32
###begin p 33
###xml 71 75 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 88 92 88 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 645 649 645 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
The selective changes in transmembrane and mitochondrial genes in COX-2-/- but not COX-1-/- may be related to the different subcellular localization of the two COX isoforms [11]. The deletion of COX-2, normally localized at nuclear envelope [11], might affect the expression of genes directly or indirectly coupled with COX-2. Although coupling between COX-2 and mitochondrial enzymes in brain has not been reported, mitochondrial localization of COX-2 has been reported in cancer cells and in corpus luteum [12,13]. Our observation that important genes involved in mitochondrial energy metabolism are upregulated in the cerebral cortex of COX-2-/- mice suggests that COX-2 is critical for mitochondrial function.
###end p 33
###begin p 34
###xml 121 125 121 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 265 267 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 268 270 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Our findings demonstrate that expressions of HADH2, ACAT1, and ACLY mRNA were upregulated in the cerebral cortex of COX-2-/- mice. The protein products of these genes work in tandem to metabolize lipids, through the process of beta oxidation, to acetyl-coenzyme A [14-16].
###end p 34
###begin p 35
###xml 177 181 171 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 288 292 282 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 298 300 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 376 380 370 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 593 595 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 674 678 662 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
The consequences of an increase in brain expression of three major enzymes involved in the beta oxidation of lipids implies an increase in beta oxidation of fatty acids in COX-2-/- mice. Supporting this hypothesis, a previous study examining the incorporation of AA in the brains of COX-2-/- mice [17] suggested that the increase in baseline incorporation of AA in awake COX-2-/- mice is possibly due to increased beta oxidation. Because a component of the kinetic model used by Rapoport and coworkers allows for the possibility of a portion of the infused AA to be shunted to beta oxidation [18], it is possible that the increased incorporation of AA in the brains of COX-2-/- mice represents increased beta oxidation mediated by an increase in HADH2, ACAT1, and ACLY. However, it remains unclear why the deletion of COX-2, but not COX-1, would result in an increase in beta oxidation enzymes in the brain.
###end p 35
###begin p 36
###xml 317 318 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 319 320 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 339 343 336 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 424 425 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 426 427 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 490 494 487 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 636 640 633 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 196 211 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
Although these enzymes function in tandem in the beta oxidation pathway of lipid metabolism, HADH2 has been shown to play a role in modifying the susceptibility of mouse brain to certain insults. Transgenic mice overexpressing HADH2 have proved to be more resistant to the brain damage associated with MCAO and MPTP [8,9]. Similarly, COX-2-/- mice also exhibit increased resistance to MPTP and MCAO induced neuronal damage [8,9]. It is unclear whether increased expression of HADH2 in COX-2-/- mice, as observed in the present study, contributed to those previous findings, but it is interesting that mice overexpressing HADH2 and COX-2-/- mice are both resistant to the aforementioned nervous system insults.
###end p 36
###begin title 37
###xml 83 87 83 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Altered expression of homocysteine metabolism genes in the cerebral cortex of COX-2-/- mice
###end title 37
###begin p 38
###xml 203 207 203 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 223 227 223 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
Our study demonstrated that the expressions of MAT2B and AHCY mRNA, the protein products of which are two tandem enzymes involved in methionine metabolism, are upregulated in the cerebral cortex of COX-2-/- but not of COX-1-/- mice.
###end p 38
###begin p 39
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
MAT2B increases the level of product inhibition of the MAT holoenzyme [19,20]. Because increased levels of S-adenosylmethionine are observed when MAT2B is downregulated [19], we could predict that increased expression of MAT2B, as observed in our study, would result in decreased S-adenosylmethionine, which is the exclusive methyl donor for transmethylation reactions [19-21].
###end p 39
###begin p 40
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 244 248 244 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 406 410 406 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 768 772 768 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 791 795 791 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
Being the sole enzyme known to metabolize S-adenosylhomocysteine, which is the product of transmethylation reactions, AHCY regulates all S-adenosylmethionine dependent methyltransferases [22]. Increased expression of AHCY in the cortex of COX-2-/- mice is predicted to increase the production of adenosine and homocysteine [23]. The suggestion that an increase in homocysteine production may occur in COX-2-/- mice is intriguing because homocysteine is known to activate endogenous glutamate receptors and potentiate the effect of certain excitotoxins such as kainic acid [24,25]. The possibility that increased expression of AHCY results in elevated homocysteine concentrations is consistent with a preliminary observation made in our laboratory indicating that COX-2-/- mice, but not COX-1-/- mice, have increased seizure intensity and neuronal damage after systemic injection with kainic acid [26]. Our findings support the observation that homocysteine pretreatment increases the intensity of kainate-induced seizures and neuronal damage [25].
###end p 40
###begin title 41
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Altered expression of GABA neurotransmission genes in COX-1-/- and COX-2-/- mice
###end title 41
###begin p 42
###xml 182 184 179 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A </sub>
###xml 217 219 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 281 283 278 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A </sub>
###xml 345 347 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 348 350 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 473 475 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 643 647 640 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 665 669 662 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
We have identified two differentially expressed genes, GABRB1 and GAT3, from the cortical and hippocampal GABAergic system of COX deficient mice. GABRB1 is a beta subunit of the GABAA ionotropic receptor ion channel [27]. GABRB1 mRNA is known to be downregulated by persistent GABAA receptor activation and in a model of temporal lobe epilepsy [28,29]. It is well established that a decrease in GABA receptor number is preceded by a decrease in GABA receptor subunit mRNA [30]. Therefore, our finding that GABRB1 mRNA expression is decreased suggests a downregulation of GABA ionotropic receptor in the hippocampus and cerebral cortex of COX-2-/- mice but not COX-1-/- mice.
###end p 42
###begin p 43
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 370 374 370 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 393 397 393 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 673 688 <span type="species:ncbi:10090">transgenic mice</span>
Coupled with changes in GABRB1 in COX-2-/- mice, we also demonstrated an alteration in the expression of a GABA transporter. This transporter, GAT3, is thought to terminate the GABA signal by transporting GABA from the synapse into the cell [31-33]. The alteration in GAT3 expression observed in the present study suggests an increased level of inhibitory input in COX-1-/- mice, whereas COX-2-/- mice may have less inhibitory input because of altered rates of GABA uptake from the synapse. In fact, increased expression of GAT3 has been demonstrated to be associated with epileptogenic hippocampal tissue [34]. Furthermore, it has been shown that overexpression of GAT in transgenic mice increases their susceptibility to kainate-induced seizures [35].
###end p 43
###begin p 44
###xml 86 90 86 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 109 113 109 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 248 252 248 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 376 380 376 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
The combined effect of decreased expression in GABRB1 and an increase in GAT3 in COX-2-/- mice, but not COX-1-/- mice, is also consistent with preliminary data from our group demonstrating an increased susceptibility of COX-2-/- mice, but not COX-1-/- mice, to kainate induced excitotoxicity [26]. The net effect of the alterations in GABA-related gene expression in the COX-2-/- mouse brain would suggest decreased GABAergic tone, predisposing these mice to an increased neuronal excitability that would increase their susceptibility to excitotoxins such as kainate. Although our observations in the present study are consistent with our previous data [26], it remains to be determined how deletion of COX-2, but not of COX-1, alters the expression of GABAergic system related genes.
###end p 44
###begin title 45
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
COX genotype-dependent alteration of Janus kinase isoforms in the mouse hippocampus
###end title 45
###begin p 46
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
JAK1 and JAK2 are non-receptor tyrosine kinases that are essential for the signal transduction of cytokine receptor activation (For reviews, see Aringer and coworkers [36] and Leonard and O'Shea [37]). Both isoforms are ubiquitously expressed but are involved in the transduction of specific groups of cytokine signals [36,37]. Furthermore, JAK1 and JAK2 knockout mice demonstrate the importance and nonredundancy of these JAK isoforms, because both mutations are lethal [36].
###end p 46
###begin p 47
###xml 98 102 98 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 177 181 177 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 259 263 259 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 522 526 522 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 535 539 535 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 772 776 768 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 785 789 781 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 795 796 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 797 798 793 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 806 810 802 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 939 940 927 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 960 964 948 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1081 1082 1061 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1246 1248 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
We found that JAK1 mRNA expression, but not that of JAK2, is increased in the hippocampus of COX-1-/- mice, and that JAK2, but not JAK1, is decreased in the hippocampus of COX-2-/- mice. Although this is the first report to demonstrate a JAK alteration in COX-/- mice, COX-2 inhibitors have been shown to dampen interleukin-12 signaling by inhibiting the activation of JAK2 [38]. Although it is unclear how these alterations affect the brain physiology of the knockout mice, one could predict a different response of COX-1-/- and COX-2-/- mice to neuroinflammation caused by the role played by JAK in regulating inflammation-induced signaling. Interestingly, the pattern of change in JAK expression is similar to what has been observed for NF-kappaB in the brains of COX-1-/- and COX-2-/- mice [6,7]. COX-1-/- mice exhibit an upregulation of the activity and expression of NF-kappaB accompanied by an increase in I-kappaB phosphorylation [6]. Conversely, COX-2-/- mice exhibit decreased expression and activation of NF-kappaB accompanied by a decrease in I-kappaB phosphorylation [7]. Although the mechanism of crosstalk between the JAKs and NF-kappaB has not been elucidated, evidence suggests that JAK may be required for NF-kappaB activation [39]. In this regard, the similarity in direction of expression of JAK and NF-kappaB based on COX isoform deficiency is intriguing and requires further study.
###end p 47
###begin title 48
Conclusion
###end title 48
###begin p 49
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
The present study is the first to demonstrate the specific effect of genetic ablation of COX-1 or COX-2 on the mouse brain transcriptome. Our findings suggest that ablation of COX activity alters the transcription of many genes, including those involved in beta oxidation, methionine metabolism, GABA neurotransmission, and cytokine signaling. Although some of the molecular mechanisms underlying these changes are not well understood at this time, these data identify metabolic and signaling pathways that were previously not known to be affected by COX. Because many anti-inflammatory and analgesic treatments, such as nonsteroidal anti-inflammatory drugs, rely on reduction in COX activity for their mechanism of action, the specific alterations observed in this study expand our understanding of the therapeutic and toxicologic consequences of COX inhibition.
###end p 49
###begin title 50
Materials and methods
###end title 50
###begin title 51
Animal procedure
###end title 51
###begin p 52
###xml 5 9 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 454 456 454 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 843 847 843 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 856 860 856 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 921 925 921 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 934 937 934 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
COX-1-/- or COX-2-/- mice and respective wild-type mice (C57BL6/6-129/Ola mixed genetic background) [4] were received at the animal facility of the National Institute on Aging at 6 weeks of age from the National Institute of Environmental Health Sciences colony maintained by Taconic Farms (Germantown, NY, USA), with heterozygous by heterozygous breedings for more than 35 generations. The heterozygotes are maintained independently for each COX line. F1 offspring of these heterozygous x heterozygous matings are then mated wild-type x wild-type to generate the wild-type mice used in the study. Male homozygous null mice (-/-) are mated with heterozygous female mice (+/-) to generate the -/- mice used in the present study. Thus, all mice used in the study were one generation from the heterozygous x heterozygous maintenance colony. COX-1-/- and COX-2-/- mice were then compared with respective wild-type mice (COX-1+/+ and COX-2+/+, respectively) for microarray and Q-PCR analysis.
###end p 52
###begin p 53
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 408 413 <span type="species:ncbi:9606">Child</span>
###xml 425 430 <span type="species:ncbi:9606">Human</span>
Mice were housed at room temperature on a 12 hour light/dark cycle with free access to food and water in a ventilated cage rack system. At 12 weeks of age the mice were killed with an overdose of sodium pentobarbital (100 mg/kg) followed by decapitation. Brains were quickly removed, dissected, and stored at -80degreesC until usage. All procedures involving mice were approved by the National Institutes of Child Health and Human Development Animal Care and Use Committee, and were performed in accordance with National Institutes of Health guidelines on the care and usage of laboratory animals.
###end p 53
###begin title 54
RNA extraction and cDNA synthesis
###end title 54
###begin p 55
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Fresh frozen mouse hippocampus and cerebral cortex were processed for RNA extraction using the Qiagen RNeasy Lipid Tissue Mini kit (Qiagen, Valencia, CA, USA) under RNAse-free conditions by following the manufacturer's suggested procedure. RNA purity and integrity were verified by examining the 260 nm/280 nm ratio using a spectrophotometer and an ethidium bromide-agarose gel imaged under UV light, respectively. Extracted RNA was resuspended in RNAse-free molecular grade water and stored at -80degreesC until use. For Q-PCR, total RNA (5 mug) was reverse transcribed using a High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA, USA) using appropriate controls to ensure the absence of genomic DNA contamination.
###end p 55
###begin title 56
Microarray procedures
###end title 56
###begin p 57
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 213 215 212 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">33</sup>
###xml 524 527 523 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 534 537 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 544 547 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 558 562 557 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 818 822 817 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 843 847 842 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 901 905 900 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 926 930 925 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1162 1164 1161 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z </italic>
###xml 1233 1235 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 325 330 <span type="species:ncbi:10090">mouse</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
Microarray procedure protocols used in the study are described in the National Institute on Aging Gene Expression and Genomic Unit website [40]. Briefly, 5 mug total RNA was reverse transcribed in the presence of 33P-dCTP, and labeled cDNA was purified using a Biospin P-30 column (Bio-Rad, Hercules, CA, USA). A custom 17 K mouse nylon membrane microarray (GEO: GPL4006) was used for the high throughput analysis, which was performed in triplicate for each sample. Labeled cDNA from cerebral cortex and hippocampus of COX-1-/-, COX-2-/-, COX-1+/+, and COX-2+/+ (three mice per group) was hybridized to the nylon array for 16 to 18 hours. Arrays were washed, dried, and apposed to a phosphoimager screen for collection of data. Differentially expressed genes were identified by comparing the microarray data from COX-1+/+ with those from COX-1-/- mice and, separately, by comparing the data from COX-2+/+ with those from COX-2-/- mice (as described below). Microarray images were processed using ArrayPro (MediaCybernetics, Silver Spring, MD, USA); the raw data were transferred to an Excel spreadsheet and normalized using an Excel macro to convert raw data to Z normalization, as previously described, with the following equation [41]:
###end p 57
###begin p 58
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z </italic>
Z (raw data) = (ln [raw data] - avg [ln(raw data)])/(std dev [ln(raw data)])
###end p 58
###begin p 59
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 793 795 793 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z </italic>
###xml 820 822 820 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 941 943 941 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
Where avg is the average of all genes of an array, and std dev is the standard deviation of all genes of an array. This conversion compresses the dataset onto a log scale, normalizes the data to be symmetric around zero, and results in a standard deviation of 1, allowing data to be compared between arrays. Differentially expressed genes were identified using DIANE 1.0, a JMP (SAS Institute, Inc., Cary, CA, USA) based program developed by VVP. (Information on availability and components of DIANE can be found on the web [42]). DIANE 1.0 takes three factors into account to identify differentially expressed genes. First, for a gene to be considered differentially expressed, it must have similar values (both direction of change and magnitude) between replicate arrays, as assessed by the Z test, which results in a P value that is calculated using a normal distribution [41]. Second, the fold change between treatments is determined by z ratio:
###end p 59
###begin p 60
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
z ratio (between treatment A and B) = (z [a] - z [b])/std dev
###end p 60
###begin p 61
###xml 78 80 78 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 267 269 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 718 720 718 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 868 870 868 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 910 912 910 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 945 947 945 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 990 992 990 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Where std dev is the standard deviation of all genes on an array. Because the z normalized data have a standard deviation of exactly 1, a significant fold change was considered to be represented by any change greater than 1.5 times the standard deviation, that is, a z ratio greater than 1.5. This threshold has been stated to result in consistent detection of differentially expressed genes [41]. To avoid detection of background level genes that may produce high fold changes and therefore contribute to false detection rates, we eliminate all genes below background by ensuring that the average intensity of a gene over replicates of treatment and control exceeds zero. This is enabled by the fact that the mean of z normalized arrays is always zero. Once processed as above, the data can be divided into five different significance levels: significance level +2 = z ratio >1.5 and significant replication (P < 0.05); significance level +1 = z ratio >1.5 and no significant replication (P > 0.05); significance level 0 = neither condition is true; significance level -1 = same as +1 but wild type > knockout; and, finally, significance level -2 = same as +2 but wild type > knockout
###end p 61
###begin p 62
###xml 276 278 276 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 561 563 561 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 418 425 <span type="species:ncbi:28980">Redwood</span>
Genes that attain significance levels of +2 and -2 are highly significant and are considered differentially expressed between experimental groups. These genes are imported to Excel from DIANE according to name, symbol, gene accession number, function, significance level, and z score. Further annotation and analysis of the microarray dataset was performed using DRAGON [43] and Ingenuity Pathways (Ingenuity Systems, Redwood City, CA, USA). We did not explicitly calculate false-positive or false-negative rates for our microarray analysis because we used the z normalization primarily as a filter for selecting candidate genes for Q-PCR validation, which was carried out as described below.
###end p 62
###begin title 63
Quantitative PCR analysis
###end title 63
###begin p 64
A total of nine genes detected by microarray analysis were validated using Q-PCR. These genes were selected because they were differentially expressed in the microarray analysis. In addition, these genes were selected for further validation because they comprised distinct biologic functions or signaling pathways, as determined by analysis using the Ingenuity Pathways software.
###end p 64
###begin p 65
###xml 34 36 34 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 350 352 350 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
Validation of microarray results (n = 5-6/group) was performed using Q-PCR, with the ABI PRISM 7000 Sequence Detection System (Applied Biosystems). To increase the sample size and further validate our microarray results, to the same set of RNA samples used for microarray analysis (n = 3), a new set of RNA samples obtained from independent animals (n = 3) was added for each experimental group for Q-PCR analysis. In order to validate both positive and negative findings of the microarray analysis completely, all possible comparisons for genotype were performed in each brain region for each gene described below. All changes detected by microarray analysis were validated by Q-PCR. However, only changes in gene expression detected by Q-PCR that were statistically significant are described in the results section, whereas Q-PCR analyses that did not detect significant differential gene expression are provided in Additional data files.
###end p 65
###begin p 66
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1103 1105 1071 1073 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 1113 1115 1081 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1240 1241 1208 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1242 1243 1210 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1337 1341 <span type="species:ncbi:10090">mice</span>
Assay-on-Demand (Applied Biosystems) primers for ACAT1 (Unigene ID-Mm.293233), MAT2B (Unigene ID-Mm.293771), AHCY (Unigene ID-Mm.330692), HADH2 (Unigene ID-Mm.6994), GAT3 (Unigene ID-Mm.258596; also known as solute carrier family 6, member 13), GABRB1 (Unigene ID-Mm.226704), JAK1 (Unigene ID-Mm.289657), JAK2 (Unigene ID-Mm.275839), and ACLY (Unigene ID-Mm.282039) were used for Q-PCR validation of microarray results. Q-PCR results for the above listed genes were normalized to phosphoglycerate kinase 1 expression levels, as previously reported [5,6]. Briefly, Taqman Universal PCR Master Mix, Assay-On-Demand primers, and cDNA samples were mixed in RNAse-free water and added to an optical 96-well reaction plate (Applied Biosystems). Negative controls containing no cDNA and a standard curve spanning three orders of magnitude of dilution were run on each plate in duplicate. Q-PCR conditions were 50degreesC for 2 min and 95degreesC for 10 min, followed by 40 cycles of 15 s at 95degreesC and 1 min at 60degreesC. The amount of target gene expression was calculated by using either the DeltaDeltaCT method [44] or by using the standard curve to determine the absolute quantity of transcript. Following the method of previous reports [5,6], relative expression values of genes are expressed as percentage of expression in wild-type mice.
###end p 66
###begin title 67
Statistical analysis
###end title 67
###begin p 68
###xml 22 24 22 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 239 241 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 378 379 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 424 425 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 477 479 475 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 493 495 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 534 536 532 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
Data are expressed as z ratio of microarray data or mean percentage difference +/- standard deviation from gene expression values in wild-type mice. Statistical analysis for Q-PCR data was performed using the freeware program Open Stat 4 [45]. For all comparisons, the F test for homogeneity of variance was first calculated. Depending on the results of the F test, an unpaired t-test assuming equal variance or an unpaired t-test assuming unequal variance was calculated. The t statistic and P value for each comparison is reported. P < 0.05 was considered statistically significant.
###end p 68
###begin title 69
Additional data files
###end title 69
###begin p 70
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
The following additional data are available with the online version of this article. Additional data file 1 provides a full list of differentially expressed genes in cerebral cortex. Additional data file 2 provides a full list of differentially expressed genes in hippocampus. Additional data file 3 provides raw data for all Q-PCR analyses.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
Additional data file 1
###end title 72
###begin p 73
A full list of differentially expressed genes in cerebral cortex.
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Additional data file 2
###end title 75
###begin p 76
A full list of differentially expressed genes in hippocampus.
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Additional data file 3
###end title 78
###begin p 79
Raw data for all Q-PCR analyses.
###end p 79
###begin p 80
Click here for file
###end p 80
###begin title 81
Acknowledgements
###end title 81
###begin p 82
This work was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The authors would like to thank Drs Saba Aid and Sang-Ho Choi for their useful experimental suggestions, technical advice, and helpful discussion regarding this manuscript, and Mr William Wood 3rd and Ms Kirstin Smith for technical support.
###end p 82
###begin article-title 83
Cyclooxygenases: structural, cellular, and molecular biology.
###end article-title 83
###begin article-title 84
Cyclo-oxygenase isoenzymes: physiological and pharmacological role.
###end article-title 84
###begin article-title 85
Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.
###end article-title 85
###begin article-title 86
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis.
###end article-title 86
###begin article-title 87
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2.
###end article-title 87
###begin article-title 88
Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappaB pathway and downstream enzymes involved in prostaglandin biosynthesis.
###end article-title 88
###begin article-title 89
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Down-regulation of brain nuclear factor-kappa B pathway in the cyclooxygenase-2 knockout mouse.
###end article-title 89
###begin article-title 90
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice.
###end article-title 90
###begin article-title 91
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.
###end article-title 91
###begin article-title 92
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain.
###end article-title 92
###begin article-title 93
Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2.
###end article-title 93
###begin article-title 94
###xml 91 96 <span type="species:ncbi:9606">human</span>
Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: implication in apoptosis resistance.
###end article-title 94
###begin article-title 95
###xml 97 100 <span type="species:ncbi:10116">rat</span>
Electron microscope immunocytochemical localization of cyclooxygenase-1 and -2 in pseudopregnant rat corpus luteum during luteolysis.
###end article-title 95
###begin article-title 96
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-20 a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
###end article-title 96
###begin article-title 97
Molecular mechanisms of fatty acid beta-oxidation enzyme catalysis.
###end article-title 97
###begin article-title 98
###xml 83 88 <span type="species:ncbi:9606">human</span>
3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease.
###end article-title 98
###begin article-title 99
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mouse.
###end article-title 99
###begin article-title 100
In vivo approaches and rationale for quantifying kinetics and imaging brain lipid metabolic pathways.
###end article-title 100
###begin article-title 101
###xml 18 23 <span type="species:ncbi:9606">human</span>
Regulation of the human MAT2B gene encoding the regulatory beta subunit of methionine adenosyltransferase, MAT II.
###end article-title 101
###begin article-title 102
S-adenosylmethionine synthesis: molecular mechanisms and clinical implications.
###end article-title 102
###begin article-title 103
###xml 67 70 <span type="species:ncbi:10116">rat</span>
Effects of thyroxine on methionine adenosyltransferase activity in rat cerebral cortex and cerebellum during postnatal development.
###end article-title 103
###begin article-title 104
Differential distribution of purine metabolizing enzymes between glia and neurons.
###end article-title 104
###begin article-title 105
Structure and function of S-adenosylhomocysteine hydrolase.
###end article-title 105
###begin article-title 106
Homocysteine as a neurotoxin in chronic alcoholism.
###end article-title 106
###begin article-title 107
Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity.
###end article-title 107
###begin article-title 108
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in cyclooxygenase-2 are more susceptible than wild-types to kainic acid excitotoxicity.
###end article-title 108
###begin article-title 109
###xml 4 7 <span type="species:ncbi:10116">rat</span>
The rat beta 1-subunit of the GABAA receptor forms a picrotoxin-sensitive anion channel open in the absence of GABA.
###end article-title 109
###begin article-title 110
###xml 37 39 37 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A </sub>
Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy.
###end article-title 110
###begin article-title 111
###xml 63 68 <span type="species:ncbi:9606">human</span>
An initiator element mediates autologous downregulation of the human type A gamma-aminobutyric acid receptor beta 1 subunit gene.
###end article-title 111
###begin article-title 112
Turnover and down-regulation of GABA(A) receptor alpha1, beta2S, and gamma1 subunit mRNAs by neurons in culture.
###end article-title 112
###begin article-title 113
###xml 50 53 <span type="species:ncbi:10116">rat</span>
Quantitation of GABA transporter 3 (GAT3) mRNA in rat brain by competitive RT-PCR.
###end article-title 113
###begin article-title 114
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Neuronal and glial localization of two GABA transporters (GAT1 and GAT3) in the rat cerebellum.
###end article-title 114
###begin article-title 115
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Differential expression patterns of GABA transporters (GAT1-3) in the rat olfactory bulb.
###end article-title 115
###begin article-title 116
###xml 58 63 <span type="species:ncbi:9606">human</span>
GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus.
###end article-title 116
###begin article-title 117
###xml 122 137 <span type="species:ncbi:10090">transgenic mice</span>
Overexpression of gamma-aminobutyric acid transporter subtype I leads to susceptibility to kainic acid-induced seizure in transgenic mice.
###end article-title 117
###begin article-title 118
Janus kinases and their role in growth and disease.
###end article-title 118
###begin article-title 119
Jaks and STATs: biological implications.
###end article-title 119
###begin article-title 120
COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis.
###end article-title 120
###begin article-title 121
Pancreatitis-associated protein I suppresses NF-kappa B activation through a JAK/STAT-mediated mechanism in epithelial cells.
###end article-title 121
###begin article-title 122
National Institute on Aging: Protocols
###end article-title 122
###begin article-title 123
Analysis of microarray data using Z score transformation.
###end article-title 123
###begin article-title 124
Overview of DIANE 1.0
###end article-title 124
###begin article-title 125
DRAGON Database Referencing of Genes Online
###end article-title 125
###begin article-title 126
###xml 99 100 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta CT) method.
###end article-title 126
###begin article-title 127
Bill Miller's Free Statistics Site!
###end article-title 127
###begin title 128
Figures and Tables
###end title 128
###begin p 129
###xml 89 93 86 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 241 245 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 549 551 546 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z </italic>
###xml 681 683 678 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
beta Oxidation gene expression is increased in cerebral cortex of cyclo-oxygenase (COX)-2-/- mice. The expression of three tandem genes involved in the metabolism of short chain fatty acids to citrate is increased in cerebral cortex of COX-2-/- mice, as determined by microarray and quantitative PCR (Q-PCR) analysis. These genes, namely hydroxyacyl coenzyme-A dehydrogenase (HADH2), acetyl coenzyme-A acetyltransferase (ACAT1) and ATP citrate lyase, are depicted in the ovals above, along with the enzyme classification (EC) number in parenthesis. Z ratio from the microarray analysis and Q-PCR validation results for each gene are provided below the name of the gene. A positive z ratio represents an increase in expression in COX knockout mice, whereas a negative value denotes a decrease in expression in COX knockout mice. Q-PCR percentage represents the percentage increase in expression over wild-type mice. HADH2 and ACAT1 are expressed in the mitochondria and ATP citrate lyase is expressed in the cytosol. The expression of genes represented as a square is not changed.
###end p 129
###begin p 130
###xml 100 104 100 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 237 241 237 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 516 518 516 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z </italic>
###xml 648 650 648 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
Methionine metabolism gene expression is increased in the cerebral cortex of cyclo-oxygenase (COX)-2-/- mice. The expression of two tandem genes involved in the metabolism of methionine to homocysteine is increased in the cortex of COX-2-/- mice, as determined by microarray and quantitative PCR (Q-PCR) analysis. These genes, namely methionine adenosyltransferase (MAT2B) and S-adenosylhomocysteine hydrolase (AHCY), are depicted in the ovals above, along with the enzyme classification (EC) number in parenthesis. Z ratio from the microarray analysis and Q-PCR validation results for each gene are provided below the name of the gene. A positive z ratio represents an increase in expression in COX knockout mice, whereas a negative value denotes a decrease in expression in COX knockout mice. Q-PCR percentage represents the percentage increase in expression over wild-type mice.
###end p 130
###begin p 131
###xml 47 51 47 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 60 64 60 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Genes whose expression is altered in both COX-1-/- and COX-2-/- mice
###end p 131
###begin p 132
###xml 59 61 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 201 205 201 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
Gene names are provided with GenBank accession numbers and z ratio. A positive z-ratio represents an increase in expression in COX-/- mice while a negative value denotes a decrease in expression in COX-/- mice. COX, cyclooxygenase.
###end p 132
###begin p 133
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Expression of GABA and JAK signaling-related genes in brain of COX knockout mice
###end p 133
###begin p 134
###xml 102 104 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z </italic>
###xml 235 239 235 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 248 252 248 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 346 347 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
Percentage change in expression, as validated by Q-PCR, is provided, along with microarray-determined z ratios (in parenthesis) for each genotype comparison. Janus kinase (JAK)1 and 2 expression are altered only in hippocampus of COX-1-/- and COX-2-/- mice. COX, cyclooxygenase; GABA, gamma-aminobutyric acid; GABRB1, GABA-A receptor subunit beta1; GAT, GABA transporter; ND, not differentially expressed in microarray analysis.
###end p 134

